[Clinical features and prognosis of patients with peripheral neuropathy with systemic light chain amyloidosis].

Le résumé fourni par la source

The clinical data and prognosis of 6 patients with systemic light chain amyloidosis-related peripheral neuropathy admitted to Huashan Hospital Affiliated to Fudan University from June 2019 to January 2024 were analyzed retrospectively, and discussed.The patients were from 48 to 70 (58±9) years, including 4 males and 2 females. Among the initial symptoms, 4 cases had both lower limb sensory abnormalities, 1 case had both upper limb numbness, pain, weakness, 1 case had swallowing disorders, 5 cases had pain and autonomic symptoms, 6 cases had weight loss, 6 cases had heart involvement, mainfested as chest tightness, shortness of breath, and 3 patients had kidney involvement, manifested as asymptomatic proteinuria. Four cases had light chain type λ, 1 case had λ+κ and i case had κ. Five cases underwent lumbar puncture with protein cell separation and CSF protein was (1.00±0.21) g.Electrophysiological examination was performed in all 6 patients, suggesting multiple peripheral nerve damage involving motor and sensory nerves and mainly axonal involvement.Four cases (4/5) had positive intestinal biopsies; 1 (1/3) cases had positive nerve biopsy; 1 (1/1) case had positive skin biopsy and 1 (0/1) had negative fat biopsy; 5 (0/5) had bone marrow biopsy, with negative Congo red staining. All 6 patients underwent chemotherapy, with only 1 improving, 3 experiencing gradually worsening symptoms, and 2 dying. Multiple peripheral nerve axonal damage and autonomic nerve involvement are characteristics of systemic light chain amyloidosis peripheral neuropathy.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.